National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant macrophage colony-stimulating factor
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous protein cytokine macrophage colony-stimulating factor (M-CSF). Synthesized endogenously by mesenchymal cells, M-CSF stimulates the survival, proliferation, and differentiation of hematopoietic cells of the monocyte-macrophage series and can reverse treatment-related neutropenias. Recombinant M-CSF may also enhance antigen presentation and activate antitumoral cytotoxic T-cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:colony stimulating factor 1
recombinant colony-stimulating factor 1
Abbreviation:rM-CSF



Previous:recombinant interleukin-18, recombinant interleukin-3, recombinant interleukin-4, recombinant interleukin-6, recombinant interleukin-7
Next:recombinant MAGE-3.1 antigen, recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A, recombinant modified vaccinia Ankara-5T4 vaccine, recombinant nematode anticoagulant protein c2, recombinant parathyroid hormone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov